Key points are not available for this paper at this time.
Mesenchymal tumours of GI tract represent a heterogenous group of neoplasms encompassing benign , intermediate, and malignant entities. In consideration of their rarity as well as of intrinsic complexity, diagnostic accuracy represents a major challenge. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the gastrointestinal (GI) tract. GISTs account for approximately 80% of the clinically relevant GI mesenchymal tumors. They are basically positive for KIT by immunohistochemistry. Almost all GISTs are negative for desmin, which is a positive marker for mature smooth muscle cells. Smooth muscle tumors such as leiomyomas and leiomyosarcomas, which usually show the spindle cell morphology, consist of approximately 10% of the clinically relevant GI mesenchymal tumors and are almost positive for desmin and negative for KIT. Thus, most GI mesenchymal tumors are differentially diagnosed by immunohistochemistry (IHC) of KIT, desmin.
Das et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: